ADVB Total Utang marang Modal Advanced Biomed Inc

ADVB (Advanced Biomed Inc) - tandha merek perusahaan

Advanced Biomed Inc (ADVB) aims for the global distribution of microfluidic systems to combat oncology. Company management is focused on validating test efficacy to ensure their inclusion in standard medical protocols. The business is currently developing high-precision tumor screening tools, and the individual debt-to-equity ratio stands at 0.08. This chart illustrates the exchange price action based on this metric.

Rasio Utang marang Ekuitas: Advanced Biomed Inc. (ADVB) kanggo 07.03.2025 - 28.10.2026
Sampel barang Advanced Biomed Inc.

This ratio determines the share of borrowed funds within the financing structure, comparing total liabilities to net assets to assess financial stability. The debt-to-equity dynamics are critical for Advanced Biomed Inc. (ADVB), as liquidity shortages and losses incurred during the development of diagnostic platforms make the business highly dependent on external leverage.

Pesaing utama

Total Utang marang Modal ONC|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc.|Total Utang marang Modal RVMD|Total Utang marang Modal AAPG (Ascentage Pharma Corp)|CGON - Utang marang Ekuitas|Rasio Utang marang Ekuitas urogen.com URGN|BCAX: Total Utang marang Modal|PSNL - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ERAS|DCTH (Delcath Corp) - Utang marang Modal|YMAB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi aurabiosciences.com (AURA)|Candel Therapeutics (CADL) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Accuray Inc (ARAY)|SELLAS Life Sciences Group - Total Utang marang Modal|ACTU - Rasio Total Utang marang Ekuitas|Citius Oncology, Inc. - Rasio Total Utang marang Ekuitas|HURA: Total Utang marang Modal|Utang marang Ekuitas Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc (FATE) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal WHWK (Aadi Bioscience, Inc.)|Utang marang Modal TScan|Total Utang marang Modal CSBR|Total Utang marang Modal xbiotech.com (XBIT)|CVM - Total Utang marang Modal|OSTX - Rasio Utang marang Ekuitas|RADX - Rasio Total Utang marang Ekuitas|ARTV - Utang marang Ekuitas|ANL: Total Utang marang Modal|VERU (verupharma.com) - Total Utang marang Modal|Utang marang Ekuitas Tempest Therapeutics, Inc. (TPST)|Rasio Utang marang Ekuitas Xilio|Total Utang marang Modal RENB (Renovaro Inc.)|Rasio Total Utang marang Ekuitas muraloncology.com (MURA)|KAPA: Total Utang marang Modal|Utang marang Modal OnKure Therapeutics, Inc. OKUR|CytoMed (GDTC) - Total Utang marang Modal|Curis, Inc. (CRIS) - Rasio Utang marang Ekuitas|Rasio Total Utang marang Ekuitas apollomicsinc.com APLM|Tharimmune Corporation (THAR) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal Genprex, Inc.|Utang marang Ekuitas Calidi Bio|SBFM (Sunshine Biopharma, Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal XBIO (xeneticbio.com)|SLRX: Utang marang Ekuitas|Kitov Pharma - Utang marang Modal|AONC: Utang marang Ekuitas|BGNE - Rasio Total Utang marang Ekuitas|Total Utang marang Modal CKPT|elevationoncology.com (ELEV) - Utang marang Modal|Total Utang marang Modal iCAD Inc. (ICAD)|Rasio Utang marang Ekuitas Ikena (IKNA)|Notable Labs, Ltd. (NTBL) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi viracta.com (VIRX)|Total Utang marang Modal MOR|NAYA Biosciences Inc - Koefisien Total Utang marang Modal|Ascentage Pharma Group Ltd (AAPGV) - Utang marang Ekuitas